Rhea-AI Summary
IO Biotech, Inc. amended a Schedule 13G to report that Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen beneficially own 0% of the company's common stock as of the close of business on March 31, 2026. The filing lists the reporting persons and their Delaware/U.S. status.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
IO Biotech, Inc. amended a Schedule 13G to report that Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen beneficially own 0% of the company's common stock as of the close of business on March 31, 2026. The filing lists the reporting persons and their Delaware/U.S. status.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many IOBTQ (IOBTQ) SEC filings are available on StockTitan?
StockTitan tracks 2 SEC filings for IOBTQ (IOBTQ), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for IOBTQ (IOBTQ)?
The most recent SEC filing for IOBTQ (IOBTQ) was filed on May 15, 2026.